21![Microsoft Word - S1CR2 Step4 Microsoft Word - S1CR2 Step4](https://www.pdfsearch.io/img/0c6db3bcbe47f9adf15a06c20d55a35c.jpg) | Add to Reading ListSource URL: www.ich.orgLanguage: English - Date: 2012-06-22 05:08:23
|
---|
22![Besifloxacin hydrochloride ClinPharm PREA Besifloxacin hydrochloride ClinPharm PREA](https://www.pdfsearch.io/img/27356b0c735c71eda74f566f554ae81d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
23![020838_Candesartan_Statistical_BPCA 020838_Candesartan_Statistical_BPCA](https://www.pdfsearch.io/img/65d6410de645754e46676f49dc473318.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
24![Medical-Statistical Review Medical Reviewer: Shari Targum, M.D. Statistical Reviewer: Valeria Freidlin, Ph.D. Drug: Valsartan Trade Name: Diovan NDA: 21-283 Medical-Statistical Review Medical Reviewer: Shari Targum, M.D. Statistical Reviewer: Valeria Freidlin, Ph.D. Drug: Valsartan Trade Name: Diovan NDA: 21-283](https://www.pdfsearch.io/img/e9ee3d334bd050e42c87203f4bb1fe2f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
25![E4: Dose Response Information to Support Drug Registration E4: Dose Response Information to Support Drug Registration](https://www.pdfsearch.io/img/1d93fe9f85d4a5d476754428790ac25c.jpg) | Add to Reading ListSource URL: www.hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:25:42
|
---|
26![A Bayesian Phase I/II Design for Oncology Clinical Trials of Combining Biological Agents Ying Yuan Department of Biostatistics, MD Anderson Cancer Center March 12, 2014 A Bayesian Phase I/II Design for Oncology Clinical Trials of Combining Biological Agents Ying Yuan Department of Biostatistics, MD Anderson Cancer Center March 12, 2014](https://www.pdfsearch.io/img/a2063c333fef0fef79f5dcd7089f1b49.jpg) | Add to Reading ListSource URL: www.rss.org.ukLanguage: English - Date: 2014-03-19 06:52:00
|
---|
27![[removed]Doc 4 V2.0 Pneumococcal Conjugate Dose Ranging Study Questions and Answers What is the purpose of this study? The purpose of this study is to see whether giving two injections of Prevnar 13® (PCV13) to adults w [removed]Doc 4 V2.0 Pneumococcal Conjugate Dose Ranging Study Questions and Answers What is the purpose of this study? The purpose of this study is to see whether giving two injections of Prevnar 13® (PCV13) to adults w](https://www.pdfsearch.io/img/0a0e28e9e93ee46708fefae66abd2fd2.jpg) | Add to Reading ListSource URL: www.grouphealthresearch.orgLanguage: English - Date: 2013-02-15 09:44:37
|
---|
28![Invitation Letter for Pneumococcal Conjugate Dose Ranging Study Invitation Letter for Pneumococcal Conjugate Dose Ranging Study](https://www.pdfsearch.io/img/14a711dcbfb35c6e889d9d258d0b1f41.jpg) | Add to Reading ListSource URL: www.grouphealthresearch.orgLanguage: English - Date: 2013-02-15 09:44:33
|
---|
29![Appointment Reminder for Pneumococcal Conjugate Dose Ranging Study Appointment Reminder for Pneumococcal Conjugate Dose Ranging Study](https://www.pdfsearch.io/img/89300f9b9ae42ce59620801cb0b93144.jpg) | Add to Reading ListSource URL: www.grouphealthresearch.orgLanguage: English - Date: 2013-02-15 09:44:27
|
---|
30![Participant Instructions for Pneumococcal Conjugate Dose Ranging Study Participant Instructions for Pneumococcal Conjugate Dose Ranging Study](https://www.pdfsearch.io/img/d6cc3b52b888ceac379aa5885efcc12f.jpg) | Add to Reading ListSource URL: www.grouphealthresearch.orgLanguage: English - Date: 2013-02-15 09:44:36
|
---|